BREAKING NEWS. The second case of leprosy confirmed in Romania. What DSP announced

Background: Understanding Leprosy and Its Historical Context in Romania

Leprosy, medically termed Hansen's disease, is a chronic infectious disease caused by Mycobacterium leprae. Characterized by skin lesions and nerve damage, it has historically been stigmatized due to its disfiguring effects. Globally, leprosy remains endemic in some regions, but in Romania, it had been virtually eradicated, with the last confirmed case reported in 1981.

The disease progresses slowly and is known for its low contagiousness, requiring prolonged close contact for transmission. Advances in medical science and public health interventions have significantly reduced its prevalence worldwide, but sporadic cases still emerge, often linked to migration or travel from endemic areas.

The recent confirmation of two cases in Romania after more than four decades marks a significant epidemiological event, necessitating careful monitoring and response by health authorities to prevent further transmission and manage potential cases effectively.

Details of the Confirmed Cases and Ongoing Investigations

On December 11, 2025, the first leprosy case in Romania in 44 years was confirmed in Cluj-Napoca, followed by a second confirmed case the very next day. Both individuals are young women, aged 21 and 25, originally from Asia, employed as masseuses at a local SPA salon. Two additional women from the same workplace are currently undergoing clinical and microbiological evaluations due to suspicious skin lesions and epidemiological links.

The initial patients presented themselves for medical evaluation on November 26, 2025, at the County Emergency Clinical Hospital (SCJU) Cluj. Diagnostic procedures included skin tissue biopsies, microscopy tests indicating the presence of acid-fast bacilli consistent with Mycobacterium leprae, and exclusion of tuberculosis through molecular genetic testing.

These investigations have been critical in confirming the diagnosis and guiding treatment. The ongoing assessments of the other two individuals involve histopathological and microbiological analyses to determine infection status and to implement timely interventions as necessary.

Clinical Features and Diagnosis of Leprosy

Leprosy manifests primarily through skin lesions that may be hypopigmented or reddish, often accompanied by numbness due to peripheral nerve involvement. Early detection is vital in preventing irreversible nerve damage and disability. In these cases, the presence of characteristic skin lesions prompted further diagnostic work-up.

Diagnostic confirmation relies on a combination of clinical evaluation, skin biopsies, and microscopic detection of Mycobacterium leprae. Advanced molecular tests help exclude other mycobacterial infections, such as tuberculosis, ensuring accurate diagnosis and appropriate treatment.

The slow progression of leprosy means symptoms may develop over months or years, which can delay diagnosis. Therefore, heightened clinical awareness and epidemiological investigations are essential when cases arise in non-endemic areas.

Treatment Protocols and WHO Guidelines in Romania

Upon confirmation of leprosy, the patients were promptly started on the World Health Organization (WHO) recommended multidrug therapy (MDT). This treatment regimen typically includes dapsone, rifampicin, and clofazimine administered over six to twelve months, depending on disease severity.

MDT is highly effective in curing leprosy, halting disease progression, and reducing transmission risk. After initiating treatment, patients rapidly become non-infectious, which is crucial for public health control measures.

Romanian health authorities emphasize adherence to international protocols to ensure successful outcomes. Continuous clinical monitoring accompanies the treatment to manage any complications and to evaluate the response to therapy.

Public Health Measures and DSP Cluj’s Response

In response to these cases, DSP Cluj has implemented stringent measures to limit any potential risk of disease spread. The SPA salon where the affected individuals worked was immediately closed pending a thorough epidemiological investigation.

The facility underwent comprehensive disinfection using ozone technology, targeting all areas used by the employees. Additional measures include the inspection of changing rooms, personal storage spaces, and intensified sanitization with approved biocides to ensure a safe environment.

Moreover, all salon employees are scheduled for medical check-ups with occupational health specialists. The investigation extends to evaluating the living and working conditions of the foreign employees to identify possible sources and transmission pathways.

Risk Assessment and Communication to the Public

DSP Cluj and the Ministry of Health have reassured the public that the risk of leprosy transmission to the general population remains very low. Leprosy requires prolonged close contact for transmission, and casual interactions such as handshakes, hugs, or shared public transport do not pose a risk.

Health authorities are committed to transparent communication and continuous monitoring to prevent panic and misinformation. The ongoing surveillance and contact tracing efforts are designed to quickly identify and manage any additional cases.

Public education campaigns are planned to raise awareness about leprosy’s characteristics, transmission modes, and the importance of early diagnosis to reduce stigma and encourage prompt medical consultation if symptoms arise.

Implications of the Cases for Romania’s Healthcare System

The emergence of leprosy cases after four decades highlights the need for vigilance in Romania’s healthcare system, especially concerning infectious diseases previously considered eradicated. It underscores the importance of maintaining diagnostic capabilities and epidemiological surveillance.

These cases also emphasize the necessity of integrating migrant health considerations into public health policies, given that the affected individuals originate from regions where leprosy remains endemic.

Healthcare providers are encouraged to update their knowledge on rare infectious diseases and maintain a high index of suspicion when encountering relevant clinical presentations, ensuring timely diagnosis and treatment to prevent complications and transmission.

Next Steps: Ongoing Monitoring and Future Preparedness

DSP Cluj continues to intensify epidemiological surveillance, clinical monitoring, and contact testing to mitigate any further spread. The two suspected cases remain under close observation, with results pending from ongoing microbiological and histopathological tests.

Authorities are also assessing the broader context, including workplace and living environments, to identify potential exposure risks and implement preventive strategies. Collaboration with international health organizations ensures adherence to best practices.

Looking ahead, Romania plans to strengthen its infectious disease preparedness frameworks, integrating lessons learned from this incident to enhance early detection, rapid response, and public communication strategies for rare but significant diseases like leprosy.

Conclusion

The confirmation of two leprosy cases in Romania after more than four decades is a rare but significant public health event. Thanks to prompt diagnosis, adherence to WHO treatment protocols, and swift action by DSP Cluj, the risk of broader transmission remains low. This situation serves as a reminder of the importance of continuous epidemiological vigilance, especially in the context of global migration. Romanian health authorities remain committed to protecting public health through rigorous investigation, transparent communication, and preventive measures. Public awareness and cooperation will be key to managing this disease effectively and preventing future outbreaks.